Characterization of potent anticholinesterase plant oil based microemulsion

International Journal of Pharmaceutics

Volumn 401, Issue 1-2, 2010, Pages 32-40

  Chaiyana, Wantida ^a   Saeio, Kiattisak ^a   Hennink, Wim E ^b   Okonogi, Siriporn ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; Butyrylcholinesterase inhibitor; Cymbopogon citratus; Essential oil; Microemulsion; Phase diagrams

Indexed keywords

ACETYLCHOLINESTERASE; ALCOHOL; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CITRUS FRUIT EXTRACT; COSURFACTANT; CYMBOPOGON CITRATUS EXTRACT; ESSENTIAL OIL; GINGER EXTRACT; HEXANOL; POLYOXYETHYLENE 10 OLEYLETHER; POLYSORBATE 20; POLYSORBATE 85; SURFACTANT; TRITON X 114; UNCLASSIFIED DRUG; VEGETABLE OIL;

ARTICLE; CITRUS FRUIT; COLORIMETRY; CONCENTRATION RESPONSE; CYMBOPOGON CITRATUS; DRUG STRUCTURE; ELECTRIC CONDUCTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; GINGER; IC 50; IONIC STRENGTH; MICROEMULSION; NONHUMAN; PH; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CHEMISTRY, PHARMACEUTICAL; CHOLINESTERASE INHIBITORS; CITRUS; COLORIMETRY; CYMBOPOGON; DRUG CARRIERS; DRUG COMPOUNDING; ELECTRIC CONDUCTIVITY; EMULSIONS; HYDROGEN-ION CONCENTRATION; OILS, VOLATILE; PLANT OILS; PLANTS, EDIBLE; SURFACE-ACTIVE AGENTS; WATER; ZINGIBERACEAE;

EID: 78049231304     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.005     Document Type: Article

References (54)

1. Adams M., Gmünder F., Hamburger M. Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature. J. Ethnopharmacol. 2007, 113:363-381.
2. Akhila A. Essential Oil Bearing Grasses: The Genus Cymbopogon 2009, Taylor & Francis Group, The United State of America.
3. Amzal B., Appel-Dingemanse S. Rivastigmine exposure provided by a transdermal patch versus capsules. Curr. Med. Res. Opin. 2007, 23:3199-3204.
4. Babak V.G., Stébé M.J. Highly concentrated emulsions: physicochemical principles of formulation. J. Disper. Sci. Technol. 2002, 23:1-22.
5. Baker R.C., Florence A.T., Ottewill R.H., Tadros T.F. Investigations into the formation and characterization of microemulsions. II. Light scattering conductivity and viscosity studies of microemulsions. J. Colloid Interface Sci. 1984, 100:332-349.
6. Bauduin P., Touraud D., Kunz W., Savelli M.P., Pulvin S., Ninham B.W. The influence of structure and composition of a reverse SDS microemulsion on enzymatic activities and electrical conductivities. J. Colloid Interface Sci. 2005, 292:244-254.
7. Ben-Moshe M., Magdassi S. Surface activity and micellar properties of anionic gemini surfactants and their analogues. Colloids Surf. A: Physicochem. Eng. Aspects 2004, 250:403-408.
8. Blanco M.M., Costa C.A.R.A., Freire A.O., Santos J.G., Costa M. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine 2009, 16:265-270.
9. Boonme P., Krauel K., Graf A., Rades T., Junyaprasert V.B. Characterization of Microemulsion Structures in the pseudoternary phase diagram of isopropyl palmitate/water/Brij 97:1-butanol. AAPS Pharm. Sci. Technol. 2006, 7.
10. Carlfors J., Blute I., Schmidt V. Lidocaine in microemulsion dermal delivery system. J. Disper. Sci. Technol. 1991, 12:467-482.
11. Chatterjee A., Chatterjee M., Ikushima Y., Mizukami F. The role of solvent on selective hydrogenation of conjugated and isolated CC of Citral (3,7-dimethyl 2,6-octadienal) - a self-consistent reaction field study. Chem. Phys. Lett. 2004, 395:143-149.
12. Craig R.E., Isabella A.A., Roger R.B.L. Traditional Trees of Pacific Islands: Their Culture, Environment, and Use 2006, Permanent Agriculture Resources, Hawaii.
13. Drew M. Solubilization, micellar catalysis, and microemulsions. Surfaces, Interfaces, and Colloids 2002, pp. 397-414. second ed.
14. Farfara D., Lifshitz V., Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J. Cell. Mol. Med. 2008, 12:762-780.
15. García S.F., Eliosa J.G., Salas P.A., Hernández-Garduza O., Ápam- Martínez D. Modeling of microemulsion phase diagrams from excess Gibbs energy models. Chem. Eng. J. 2001, 84:257-274.
16. Greig N.H., Utsuki T., Wang Y., Ingram D.K., Mamczar J., Rogers J., Yun Q.S., Holloway H.W., Perry T.A., Sambamurti K., Scali C., Pepeu G., Lahiri D.K. P1-414 selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers amyloid-beta peptide in rodents: a new treatment strategy for Alzheimer's disease. Neurobiol. Aging 2004, 25:S216-S1216.
17. Guginski G., Luiz A.P., Silva M.D., Massaro M., Martins D.F., Chaves J., Mattos R.W., Silveira D., Ferreira V.M.M., Calixto J.B., Santos A.R.S. Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice. Pharmacol. Biochem. Behav. 2009, 93:10-16.
18. Han A.R., Kim M.S., Jeong Y.H., Lee S.K., Seo E.K. Cyclooxygenase-2 inhibitory phenylbutenoids from the rhizomes of Zingiber cassumunar. Chem. Pharm. Bull. 2005, 53:1466-1468.
19. Hanny W.C., George C. Oriental natural flavor: liquid and spray-dried flavor of " Jeruk purut" (Citrus hystrix DC) leaves. Dev. Food Sci. 1995, 235-248.
20. Holmberg K., Jonsson B., Kronberg B., Lindman B. Surfactants and Polymers in Aqueous Solution 1998, John Wiley & Sons, Ltd., Chichester.
21. Ingkaninan K., Changwijit K., Suwanborirux K. Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root. J. Pharm. Pharmacol. 2006, 58:847-852.
22. Kovarik Z., Radic Z., Grgas B., Skrinjaric-Spoljar M., Reiner E., Simeon-Rudolf V. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline. BBA-Protein Struct. M 1999, 1433:261-271.
23. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 2002, 54:S77-S98.
24. Kumar P., Mittal K.L. Handbook of Microemulsion Science and Technology 1999, Marcel Dekker, Inc., New York, pp. 755-756.
25. Lawrence M.J., Rees G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 2000, 45:89-121.
26. Lefevre G., Pommier F., Sedek G., Allison M., Huang H.L., Kiese B., Ho Y.Y., Appel-Dingemanse S. Pharmacokinetics and bioavailability of the novel Rivastigmine transdermal patch versus Rivastigmine oral solution in healthy elderly subjects. J. Clin. Pharmacol. 2008, 48:246-252.
27. Leimann F.V., Gonçalves O.H., Machado R.A.F., Bolzan A. Antimicrobial activity of microencapsulated lemongrass essential oil and the effect of experimental parameters on microcapsules size and morphology. Mater. Sci. Eng. C 2009, 29:430-436.
28. Li X., Kunieda H. Catanionic surfactants: microemulsion formation and solubilization. Curr. Opin. Colloid Interface Sci. 2003, 8:327-336.
29. Liu D., Ma J., Cheng H., Zhao Z. Solubilization behavior of mixed reverse micelles: effect of surfactant component, electrolyte concentration and solvent. Colloids Surf. A: Physicochem. Eng. Aspects 1998, 143:59-68.
30. Mercier F., Lefèvre G., Huang H.L., Schmidli H., Amzal B., Appel-Dingemanse S. Rivastigmine exposure provided by a transdermal patch versus capsules. Curr. Med. Res. Opin. 2007, 23(12):3199-3204.
31. Martin A.N. Physical pharmacy. Am. J. Med. Sci. 1961, 241:138-140.
32. Mo C., Zhong M., Zhong Q. Investigation of structure and structural transition in microemulsion systems of sodium dodecyl sulfonate+n-heptane+n-butanol+water by cyclic voltammetric and electrical conductivity measurements. J. Electroanal. Chem. 2000, 493:100-107.
33. Moulik S.P., Paul B.K. Structure, dynamics and transport properties of microemulsions. Adv. Colloid Interface Sci. 1998, 78:99-195.
34. Mukherjee P.K., Kumar V., Mal M., Houghton P.J. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007, 14:289-300.
35. Ordentlich A., Barak D., Kronman C., Flashner Y., Leitner M., Segall Y., Ariel N., Cohen S., Velan B., Shafferman A. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J. Biol. Chem. 1993, 268:17083-17095.
36. Pan L., Tan J.H., Hou J.Q., Huang S.L., Gu L.Q., Huang Z.S. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Bioorg. Med. Chem. Lett. 2008, 18:3790-3793.
37. Paolino D., Ventura C.A., Nisticò S., Puglisi G., Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int. J. Pharm. 2002, 244:21-31.
38. Pedro A.S., Cabral-Albuquerque E., Ferreira D., Sarmento B. Chitosan: an option for development of essential oil delivery systems for oral cavity care?. Carbohydr. Polym. 2009, 76:501-508.
39. Perry E., Perry R., Blessed G., Tomlinson B. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Neurobiological 1978, 4:273-277.
40. Pithayanukul P., Tubprasert J., Wuthi-Udomlert M. In vitro antimicrobial activity of Zingiber cassumunar (Plai) oil and a 5% Plai oil gel. Phytother. Res. 2007, 21:164-169.
41. Pudil F., Wijaya H., Janda V., Volfová J., Valentová H., Pokorny J. Changes in citrus hystrix oil during autooxidation. Dev. Food Sci. 1998, 40:707-718.
42. Radić Z., Pickering N.A., Vellom D.C., Camp S., Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 1993, 32:12074-12084.
43. Rauber C.S., Guterres S.S., Schapoval E.E.S. LC determination of citral in Cymbopogon citratus volatile oil. J. Pharm. Biomed. Anal. 2005, 37:597-601.
44. Sagitani H., Friberg S. Microemulsion systems with a non-ionic cosurfactant. J. Disper. Sci. Technol. 1980, 1:1151-1164.
45. Sakulku U., Nuchuchua O., Uawongyart N., Puttipipatkhachorn S., Soottitantawat A., Ruktanonchai U. Characterization and mosquito repellent activity of citronella oil nanoemulsion. Int. J. Pharm. 2009, 372:105-111.
46. Scarpini E., Schelterns P., Feldman H. Treatment of Alzheimer's disease; current status and new perspectives. Lancet Neurol. 2003, 2:539-547.
47. Shafferman A., Barak D., Stein D., Kronman C., Velan B., Greig N.H., Ordentlich A. Flexibility versus " rigidity" of the functional architecture of AChE active center. Chem. Biol. Interact. 2008, 175:166-172.
48. Sinico C., De Logu A., Lai F., Valenti D., Manconi M., Loy G., Bonsignore L., Fadda A.M. Liposomal incorporation of Artemisia arborescens L. essential oil and in vitro antiviral activity. Eur. J. Pharm. Biopharm. 2005, 59:161-168.
49. Sintov A.C., Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control. Release 2004, 95:173-183.
50. Snyder S.E., Gunupudi N., Sherman P.S., Butch E.R., Skaddan M.B., Kilbourn M.R., Koeppe R.A., Kuhl D.E. Radiolabeled cholinesterase substrates [colon] in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. J. Cereb. Blood Flow Metab. 2001, 21:132-143.
51. Steflitsch W., Steflitsch M. Clinical aromatherapy. J. Mens Health 2008, 5:74-85.
52. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carrier Syst. 1999, 16:461-521.
53. Yang Z., Xi J., Li J., Qu W. Biphasic effect of citral, a flavoring and scenting agent, on spatial learning and memory in rats. Pharmacol. Biochem. Behav. 2009, 93:391-396.
54. Yuan Y., Li S., Mo F., Zhong D. Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm. 2006, 321:117-123.